Results 241 to 250 of about 122,604 (290)

Tamoxifen and the endometrium

1998
Tamoxifen, a nonsteroidal antiestrogen, was first approved by the Food and Drug Administration in 1978 for the treatment of patients with breast cancer. Large clinical trials involving over 75,000 patients have demonstrated an improved recurrence-free and overall survival benefit in both premenopausal and postmenopausal women.
openaire   +2 more sources

Tamoxifen as an immunotherapy

Science Signaling, 2017
Antiestrogen drugs may treat some estrogen receptor–negative tumors by limiting the proliferation and activity of suppressive immune cells.
openaire   +2 more sources

SAFETY OF TAMOXIFEN

The Lancet, 1978
J S, Patterson, M, Baum
openaire   +4 more sources

TAMOXIFEN PROPHYLAXIS

The Lancet, 1986
Gazet, J. C., Basco, V. E., Coppin, C. M.L., Rebbeck, P. M., Daly, Michael J., Wong, Wilson, Pike, M. C., Coleman, M. P., Milner, Philip, Johnson, Ian, Birch, Stephen, Williams, Brian, Simpson, H. W., Candlish, W.   +13 more
openaire   +5 more sources

Tamoxifen and the gynaecologist

BJOG: An International Journal of Obstetrics & Gynaecology, 1994
R E, Hopkins, M, Tasker
openaire   +2 more sources

Tamoxifen and the gynaecologist

BJOG: An International Journal of Obstetrics & Gynaecology, 1993
P, Neven, J H, Shepherd, D G, Lowe
openaire   +2 more sources

Tamoxifen and the uterus

European Journal of Cancer, 1998
I, Vergote, P, Neven, G, Vanderick, P, van Dam, Y, Van Belle, P h, De Sutter, F, De Prins, X, De Muylder, J, Claerhout, R, Campo, G, Albertyn   +10 more
openaire   +2 more sources

Tamoxifen

Reactions Weekly, 2023
  +4 more sources

TAMOXIFEN

The Lancet, 1987
openaire   +2 more sources

TAMOXIFEN FOR MASTALGIA

The Lancet, 1986
J.A. Smallwood, I. Taylor, I.S. Fentiman, M. Caleffi, K. Brame, M.A. Chaudary, J.L. Hayward   +6 more
openaire   +2 more sources